AcelRx Pharmaceuticals (ACRX) Posts Q1 Loss of 22c/Share
Tweet
Share
E-mailGet Alerts ACRX Hot Sheet
Join SI Premium – FREE
AcelRx Pharmaceuticals (NASDAQ: ACRX) reported Q1 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23).
For earnings history and earnings-related data on AcelRx Pharmaceuticals (ACRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform
- JPMorgan Upgrades Amber Enterprises India Ltd (AMBER:IN) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
